These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35999599)

  • 1. Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis.
    Duo H; Li Y; Sun Y; Wei L; Wang Z; Fang F; Zhong Y; Huang J; Luo L; Peng Z; Pan H
    Thromb J; 2022 Aug; 20(1):47. PubMed ID: 35999599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
    Ortega-Paz L; Galli M; Capodanno D; Franchi F; Rollini F; Bikdeli B; Mehran R; Montalescot G; Gibson CM; Lopes RD; Andreotti F; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):677-686. PubMed ID: 34519777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis.
    Zhang S; Li Y; Liu G; Su B
    Thromb J; 2021 Nov; 19(1):91. PubMed ID: 34819094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials.
    Pilia E; Belletti A; Fresilli S; Finco G; Landoni G
    J Thromb Thrombolysis; 2022 Oct; 54(3):420-430. PubMed ID: 35922578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient, and postdischarge prophylaxis: a meta-analysis of randomized controlled trials.
    Meng J; Tang H; Xiao Y; Liu W; Wu Y; Xiong Y; Gao S
    Int J Surg; 2024 Jun; 110(6):3910-3922. PubMed ID: 38549227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis.
    Gratz J; Wiegele M; Maleczek M; Herkner H; Schöchl H; Chwala E; Knöbl P; Schaden E
    Front Med (Lausanne); 2021; 8():647917. PubMed ID: 33768106
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis.
    Wills NK; Nair N; Patel K; Sikder O; Adriaanse M; Eikelboom J; Wasserman S
    medRxiv; 2022 Mar; ():. PubMed ID: 35291298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
    Wills NK; Nair N; Patel K; Sikder O; Adriaanse M; Eikelboom J; Wasserman S
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac285. PubMed ID: 35859991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients a systematic review and meta-analysis of randomized controlled trials.
    Bonfim LCMG; Guerini IS; Zambon MG; Pires GB; Silva ACF; Gobatto ALN; Lopes MA; Brosnahan SB
    J Crit Care; 2023 Oct; 77():154344. PubMed ID: 37244209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in COVID-19 patients - An updated systematic review and meta-analysis.
    Reis S; Popp M; Schießer S; Metzendorf MI; Kranke P; Meybohm P; Weibel S
    Thromb Res; 2022 Nov; 219():40-48. PubMed ID: 36113402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant Treatment Regimens in Patients With Covid-19: A Meta-Analysis.
    Jorda A; Siller-Matula JM; Zeitlinger M; Jilma B; Gelbenegger G
    Clin Pharmacol Ther; 2022 Mar; 111(3):614-623. PubMed ID: 34862791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies.
    Pilia E; Belletti A; Fresilli S; Lee TC; Zangrillo A; Finco G; Landoni G;
    Lung; 2023 Apr; 201(2):135-147. PubMed ID: 36738324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies.
    Elsebaie MAT; Baral B; Elsebaie M; Shrivastava T; Weir C; Kumi D; Birch NW
    TH Open; 2022 Oct; 6(4):e323-e334. PubMed ID: 36299621
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulation for people with cancer and central venous catheters.
    Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of Safety and Efficacy of Anticoagulation versus no Anticoagulation in Octogenarians and Nonagenarians with Atrial Fibrillation.
    Barssoum K; Kumar A; Thakkar S; Sheth AR; Kharsa A; Ibrahim M; Rai D; Idemudia O; Akula N; Patel HP; Mowafy A; Elkaryoni A; Ibrahim F; Mubasher M; Ghattas KN; Rao M
    High Blood Press Cardiovasc Prev; 2021 May; 28(3):271-282. PubMed ID: 33742366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of prophylactic anticoagulation versus therapeutic anticoagulation in hospital-admitted COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    Rauniyar R; Kuikel S; Mishra A; Rauniyar R; Yadav S; Thapaliya S; Nepal AS; Rauniyar R
    Clin Respir J; 2023 Feb; 17(2):73-79. PubMed ID: 36572657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis.
    Lee HJ; Jang HJ; Choi WI; Joh J; Kim J; Park J; Choi M
    Acute Crit Care; 2023 May; 38(2):160-171. PubMed ID: 37313662
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.